Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;30(10):1175-1192.
doi: 10.2174/0929867329666220801145639.

Research Progress on Small Molecules Inhibitors Targeting TRK Kinases

Ju Liu  1   2   3 , Yadong Zhang  1 , Yan Zhu  1 , Lu Tian  1 , Mingrui Tang  1 , Jiwei Shen  1   2   3 , Ye Chen  1   2   3 , Shi Ding  1   2   4
Affiliations

Research Progress on Small Molecules Inhibitors Targeting TRK Kinases

Ju Liu et al. Curr Med Chem. 2023.

Abstract

Background: Trk gene fusions are an important driver in the development of cancers, including secretory breast cancer and infantile congenital sarcoma. Since the first-generation of small molecule Trk inhibitors (Larotrectinib and Entrectinib) came to market, research on small molecule TRK inhibitors, especially second-generation inhibitors that break through the resistance problem, has developed rapidly. Therefore, this article focuses on the research progress of first-generation drugs and second-generation drugs that break through drug resistance.

Methods: We used the database to search for relevant and cutting-edge documents, and then filtered and selected them based on the content. The appropriate articles were analyzed and classified, and finally, the article was written according to the topics.

Results: The phenomenon of Trk protein fusion and its relation to tumors are described, followed by an explanation of the composition and signaling pathways of Trk kinases. The representative Trk inhibitors and the development of novel Trk inhibitors are classified according to whether they overcome drug resistance problems.

Conclusion: This paper provides a theoretical reference for the development of novel inhibitors by introducing and summarizing the representative and novel Trk inhibitors that break through the drug resistance problem.

Keywords: Trk gene fusions; Trk inhibitors; Trk kinases; drug resistance; overcoming drug resistance; tumors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Snider W.D.; Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell 1994,77(5),627-638 - DOI - PubMed
    1. Amatu A.; Sartore-Bianchi A.; Bencardino K.; Pizzutilo E.G.; Tosi F.; Siena S.; Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer. Ann Oncol 2019,8,5-15
    1. Drilon A.; TRK inhibitors in TRK fusion-positive cancers. Ann Oncol 2019,30(8),23-30 - DOI
    1. Huse M.; Kuriyan J.; The conformational plasticity of protein kinases. Cell 2002,109(3),275-282 - DOI - PubMed
    1. Chao M.V.; Neurotrophins and their receptors: A convergence point for many signalling pathways. Nat Rev Neurosci 2003,4(4),299-309 - DOI - PubMed